 In addition new branches were established in Poland and France.Several different problems in Poland and Hungary triggered a country-exclusive restructuring process in 1997 and was accompanied with a 100% takeover of the Austrian company Hestag and the renaming of Schulze Pharma France in PHOENIX Pharma during the same year.The entry into the United Kingdom market occurred in 1998 with the establishment of 11 distribution centres, a wholesale network with almost nationwide coverage.